The successful development of innovative pharmaceutical technologies requires a seamless integration of manufacturing design with regulatory and clinical strategy. This presentation explores the critical components involved in designing a development and manufacturing plan for new drug products and delivery systems, including aspects on Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and the Target Product Profile (TPP). It will highlight how early alignment of these elements ensures quality, safety, and scalability—while directly influencing the efficiency and structure of clinical trials and commercial manufacturing. The focus will be on oral solid drug products.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
Great networking, new knowledge and inspiration!
Jonas Rimbäck
University of Gothenburg, Sweden
The best opportunity to learn and discuss common issues and interests directly with peers.
Ian Nicoud
LURIS, Netherlands
Working and Learning with old and new friends – best way to do it!
Sara Matt-Leubner
University of Innsbruck, Austria
The expert-panel discussion educated me in strategic and meritorious choice of inventions to approach investors and manage investment funds for establishing a spin off.
Ram Siddappa
Erasmus MC, Netherlands
The course Software Specific Challenges is a must for every TTO/KTO professional, especially for those working with Social Sciences and Humanities!
Brechtje Vreenegoor
Radboud University, Netherlands
Join our newsletter and get the latest news